NASDAQ:SCTL

Societal CDMO (SCTL) Stock Price, News & Analysis

$1.10
+0.01 (+0.92%)
(As of 04/8/2024)
Today's Range
$1.09
$1.10
50-Day Range
$0.46
$1.10
52-Week Range
$0.26
$1.28
Volume
514,600 shs
Average Volume
957,342 shs
Market Capitalization
$116.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.80

Societal CDMO MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
63.6% Upside
$1.80 Price Target
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.74 out of 5 stars

Medical Sector

620th out of 910 stocks

Pharmaceutical Preparations Industry

279th out of 426 stocks

SCTL stock logo

About Societal CDMO Stock (NASDAQ:SCTL)

Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecules in the United States and internationally. The company provides end-to-end services, such as formulation development focusing on complex formulations, reformulation, physical characterization, and excipient compatibility; analytical methods development which offers a range of analytical testing capabilities, including product testing, ICH stability, method development and validation, chromatography and spectroscopy equipment, stability chambers, and microbial testing; and pharmaceutical manufacturing that provides milling, blending, compression, spray and rotary granulation, particle and bead coating, encapsulation, liquids, lyophilization, and sterile fill and finish services. It also offers regulatory support, including handling communications with the food and drug administration (FDA) and seek consultation and guidance for client FDA meetings and responses; and pharmaceutical packaging and logistics, as well as smaller-scale primary and secondary packaging, labeling and kitting options suited for clinical trial materials and development packaging needs across dosage forms. The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.

SCTL Stock Price History

SCTL Stock News Headlines

Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
Why Is Societal CDMO (SCTL) Stock Up 133% Today?
Societal CDMO Inc SCTL
Recap: Societal CDMO Q3 Earnings
Earnings Preview: Societal CDMO
See More Headlines
Receive SCTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Societal CDMO and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/22/2024
Today
4/23/2024
Next Earnings (Estimated)
5/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SCTL
Employees
258
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.80
High Stock Price Target
$2.50
Low Stock Price Target
$1.10
Potential Upside/Downside
+63.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$-13,270,000.00
Pretax Margin
-13.89%

Debt

Sales & Book Value

Annual Sales
$94.64 million
Book Value
$0.56 per share

Miscellaneous

Free Float
97,658,000
Market Cap
$116.26 million
Optionable
Optionable
Beta
1.61
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Wayne B. Weisman J.D. (Age 68)
    Executive Chairman of the Board
    Comp: $85k
  • Mr. J. David Enloe Jr. (Age 60)
    President, CEO & Director
    Comp: $1.02M
  • Mr. Ryan D. Lake CPA (Age 47)
    Senior VP & CFO
    Comp: $716.26k
  • Mr. Marshall Rizzo M.B.A.
    Senior VP & COO
  • Mr. Richard Sidwell Ph.D.
    Senior VP & Chief Scientific Officer
  • Ms. Cristin Grove
    Vice President of Sales
  • Ms. Erica Raether M.A.
    Senior VP & Chief People Officer

SCTL Stock Analysis - Frequently Asked Questions

Should I buy or sell Societal CDMO stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Societal CDMO in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" SCTL shares.
View SCTL analyst ratings
or view top-rated stocks.

What is Societal CDMO's stock price target for 2024?

3 Wall Street analysts have issued 12-month target prices for Societal CDMO's stock. Their SCTL share price targets range from $1.10 to $2.50. On average, they predict the company's share price to reach $1.80 in the next year. This suggests a possible upside of 63.6% from the stock's current price.
View analysts price targets for SCTL
or view top-rated stocks among Wall Street analysts.

How have SCTL shares performed in 2024?

Societal CDMO's stock was trading at $0.3505 at the beginning of 2024. Since then, SCTL stock has increased by 213.8% and is now trading at $1.10.
View the best growth stocks for 2024 here
.

Are investors shorting Societal CDMO?

Societal CDMO saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 2,400 shares, a drop of 99.1% from the March 15th total of 271,500 shares. Based on an average trading volume of 7,100 shares, the short-interest ratio is presently 0.3 days.
View Societal CDMO's Short Interest
.

When is Societal CDMO's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our SCTL earnings forecast
.

How were Societal CDMO's earnings last quarter?

Societal CDMO, Inc. (NASDAQ:SCTL) released its quarterly earnings results on Friday, March, 22nd. The company reported ($0.01) earnings per share for the quarter. The company earned $27.72 million during the quarter, compared to analyst estimates of $25.50 million. Societal CDMO had a negative trailing twelve-month return on equity of 23.82% and a negative net margin of 14.03%.

How do I buy shares of Societal CDMO?

Shares of SCTL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SCTL) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners